🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-center, open-label, phase II randomized controlled trial is to e...
Status
Suspended
Location
Sun Yat-sen Memorial Hospital
Start Date
2016-09
Trial ID
NCT02897050
In this multicenter, randomized phase III trial, node positive early breast...
Status
Completed
Location
Federico Castiglione
Start Date
1996-11
Trial ID
NCT02450058
Treatments Being Tested
This diagnostic clinical trial will be conducted according to a randomized,...
Status
Completed
Location
Department of Biomedical Imaging and Image-guided Therapy
Start Date
2016-01
Trial ID
NCT02659527
Treatments Being Tested
To investigate the sensitivity of the \[18F\]fluoroethylcholine (FEC) Posit...
Status
Completed
Location
German Federal Armed Forces Hospital
Start Date
2007-12
Trial ID
NCT00520546
Glutamine, a non essential branched chain amino acid, is most important non...
Status
Completed
Location
Sir Sunder Lal Hospital
Start Date
2007-12
Trial ID
NCT00772824
Treatments Being Tested
The purpose of this study is to assess the feasibility of Ixabepilone (4 cy...
Status
Completed
Location
Azienza Osped.Treviglio - Caravaggio
Start Date
2008-09
Trial ID
NCT00751868
Treatments Being Tested
The purpose of this study is to assess the pathological response rate in op...
Status
Completed
Location
Centre Jean Perrin
Start Date
2009-09
Trial ID
NCT00933517
Treatments Being Tested
This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00976989
Treatments Being Tested
The main objective of this randomized trial is to compare 6 FEC100 to 4 FEC...
Status
Unknown
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00189644
Treatments Being Tested
Adjuvant chemotherapy with the protocol 3 cure of 5-FU + Epirubicine + Cycl...
Status
Completed
Location
CGFL
Start Date
2015-11-05
Trial ID
NCT02840890
Treatments Being Tested